Outcome of patients with relapsed/refractory acute lymphoblastic leukemia after blinatumomab failure: No change in the level of CD19 expression
暂无分享,去创建一个
H. Einsele | M. Konopleva | H. Kantarjian | G. Garcia-Manero | J. Cortes | F. Ravandi | E. Jabbour | N. Daver | S. O'brien | J. Khoury | N. Jain | N. Short | W. Wierda | M. Topp | M. Yilmaz | P. Thompson | J. Düll